Auristatin F is a potent microtubule inhibitor and vascular damaging agent. Auristatin F is part of the approved drug belantamab mafodotin for multiple myeloma and some experimental anti-cancer antibody drug conjugates (ADCs).
Usually ships within 24 hours.